Protein C News and Research

RSS

Antibodies' neutralization efficacy against Omicron variants BA.1 And BA.2 wanes rapidly, study finds

The Omicron variant of the SARS-CoV-2 virus was first detected in South Africa in November 2021. The high level of infectiousness of the virus and its ability to quickly spawn additional variants has also been observed in Germany: Since January 2022 the Omicron variant BA.1 has dominated here, followed in subsequent months by the variant BA.2.

22 Jul 2022

Study examines the maintenance of immunity to SARS-CoV-2 after natural infection or post-vaccination

A new study examined the maintenance of memory B cell responses to SARS-CoV-2, the virus that causes COVID-19, after recovery from natural infection or post-vaccination.

22 Jul 2022

Oligomeric molecular structure of the MOR-Gal1R complex revealed

A study published in the journal Pharmacological Research reveals the oligomeric molecular structure of the MOR-Gal1R complex, a component present in the brain which is involved in the analgesic and addictive effects of certain opioids.

22 Jul 2022

IUPUI researchers are developing a fast, efficient COVID-19 biosensor

As the BA.5 omicron variant continues to spread, health experts are increasingly preparing for a future in which such COVID-19 variants emerge, surge and recede similar to seasonal flu.

21 Jul 2022

New AI software can create proteins that may be useful as vaccines, cancer treatments

Scientists have developed artificial intelligence software that can create proteins that may be useful as vaccines, cancer treatments, or even tools for pulling carbon pollution out of the air.

21 Jul 2022

Study may help overcome some obstacles to the development of nanoparticle-based drugs

Using nanoparticles to deliver cancer drugs offers a way to hit tumors with large doses of drugs while avoiding the harmful side effects that often come with chemotherapy.

21 Jul 2022

Alzheimer's disease and anti-amyloid therapeutic approaches

An estimated 50 million people around the world have Alzheimer's disease (AD), and perhaps twice that number are unknowingly "incubating" the disease during its long presymptomatic period.

21 Jul 2022

A different approach to build a more durable, broadly effective COVID-19 vaccine

Researchers at University of California San Diego School of Medicine, with colleagues elsewhere, describe a different way to build a COVID-19 vaccine, one that would, in theory, remain effective against new and emerging variants and could be taken as a pill, by inhalation or other delivery methods.

21 Jul 2022

Cancer cells produce small amount of collagen that impacts tumor microbiome and immunity

Cancer cells produce small amounts of their own form of collagen, creating a unique extracellular matrix that affects the tumor microbiome and protects against immune responses, according to a new study by researchers at The University of Texas MD Anderson Cancer Center.

21 Jul 2022

Phase 2a clinical trial describes safety and efficacy of dendrimer nanotherapy in severe COVID-19 patients

A multicenter, randomized, placebo-controlled phase 2a clinical trial has recently been conducted to evaluate the efficacy of a nanotherapeutic compound OP-101 in treating severe COVID-19 patients.

21 Jul 2022

Associations between whole blood viscosity and SARS-CoV-2-linked death

Researchers depicted the link between COVID-19-associated mortality and whole blood viscosity (WBV).

21 Jul 2022

Immuno-infrared sensor identifies Alzheimer's disease in the blood up to 17 years in advance

A sensor identifies misfolded protein biomarkers in the blood. This offers a chance to detect Alzheimer's disease before any symptoms occur. Researchers intend to bring it to market maturity.

21 Jul 2022

Pigment epithelium-derived factor ablations may lead to eye aging

Researchers identified that loss of pigment epithelium-derived factor (PEDF) may cause aging in the eye.

21 Jul 2022

Unlocking the power of proteins to better understand human health

We speak to Andrew Lynn, the chief executive at Fluidic Analytics, about the role proteins play in understanding human disease.

From Fluidic Analytics 21 Jul 2022

Anti-SARS-CoV-2 nucleocapsid antibodies and pre-existing lung diseases may be independent predictors of long COVID

Researchers evaluated the incidence of long coronavirus disease (long COVID) in a demographically diverse population with different disease severities to inform clinicians and future vaccine development strategies.

21 Jul 2022

Is monkeypox a global public-health emergency?

A summary of available knowledge on the monkeypox virus including pathogenicity, risk to the human population, and strategies that can help limit its spread.

20 Jul 2022

High-level resistance of SARS-CoV-2 BA.4 against neutralizing antibodies

Researchers evaluates the sensitivity of BA.4 in both vaccinated and unvaccinated individuals infected with the SARS-CoV-2 variants.

20 Jul 2022

How the Omicron variant shifted the biology of SARS-CoV-2

Researchers discuss significant antigenic changes within the spike protein of new SARS-CoV-2 VOCs like the Omicron variant.

20 Jul 2022

Stopping 'budding' viruses in their tracks

Paramyxoviruses have the potential to trigger a devastating pandemic. This family of viruses includes measles, Nipah virus, mumps, Newcastle disease and canine distemper.

20 Jul 2022

How does vitamin D supplementation impact COVID-19 vaccine efficacy?

Researchers assessed the impact of vitamin D supplementation on the efficacy of SARS-CoV-2 vaccines.

20 Jul 2022

Protein C News and Research

Antibodies' neutralization efficacy against Omicron variants BA.1 And BA.2 wanes rapidly, study finds

Study examines the maintenance of immunity to SARS-CoV-2 after natural infection or post-vaccination

Oligomeric molecular structure of the MOR-Gal1R complex revealed

IUPUI researchers are developing a fast, efficient COVID-19 biosensor

New AI software can create proteins that may be useful as vaccines, cancer treatments

Study may help overcome some obstacles to the development of nanoparticle-based drugs

Alzheimer's disease and anti-amyloid therapeutic approaches

A different approach to build a more durable, broadly effective COVID-19 vaccine

Cancer cells produce small amount of collagen that impacts tumor microbiome and immunity

Phase 2a clinical trial describes safety and efficacy of dendrimer nanotherapy in severe COVID-19 patients

Associations between whole blood viscosity and SARS-CoV-2-linked death

Immuno-infrared sensor identifies Alzheimer's disease in the blood up to 17 years in advance

Pigment epithelium-derived factor ablations may lead to eye aging

Unlocking the power of proteins to better understand human health

Anti-SARS-CoV-2 nucleocapsid antibodies and pre-existing lung diseases may be independent predictors of long COVID

Is monkeypox a global public-health emergency?

High-level resistance of SARS-CoV-2 BA.4 against neutralizing antibodies

How the Omicron variant shifted the biology of SARS-CoV-2

Stopping 'budding' viruses in their tracks

How does vitamin D supplementation impact COVID-19 vaccine efficacy?

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News